Danaher
In Brief This Week: Roche, Myriad Genetics, Danaher, and More
News items for the in vitro diagnostics industry for the week of Sept. 13, 2021.
Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business
The firms have agreed to transition the business to Beckman, with Quidel receiving annual payments until 2029.
Danaher Q2 Revenues Rise 37 Percent, Driven by Life Sciences and Diagnostics Businesses
The company beat Wall Street analysts' average estimates for the quarter on both the top and bottom line.
In Brief This Week: Quest Diagnostics, Ginkgo Bioworks, Novacyt, Danaher, and More
News items for the in vitro diagnostics industry for the week of May 3, 2021.
Danaher Q1 Revenues Up 58 Percent
The firm beat the consensus Wall Street estimate on the top line as its Life Sciences revenues grew 115 percent and its Diagnostics revenue rose 34 percent.
Jan 28, 2021
Danaher Q4 Revenues up 39 Percent
Oct 22, 2020
Danaher Q3 Revenues Up 35 Percent
Sep 30, 2020
Danaher Prices $1B Senior Notes Offering
Jul 23, 2020